Tibetan butter and Indian ghee are both fat products derived from cow’s milk or other dairy products that are rich in nutrients. Although both Tibetan butter and Indian ghee are primarily produced by filtering, heating, separating, cooling, and molding, there are differences in their production processes. Tibetan butter is produced in a process similar to that of butter, while Indian ghee is clarified butter obtained by further extraction based on the obtained butter. Both types of ghee are susceptible to adulteration; Indian ghee is primarily adulterated with vegetable oils, animal fats, and other fats or non-fats, while Tibetan butter is typically adulterated with animal body fat and non-fats, including mashed potatoes. There are numerous research reports on the detection techniques for adulteration in Indian ghee, while there are very few reports on the detection technology for adulteration of Tibetan butter. Studies have shown that techniques such as gas chromatography (GC), Fourier-transform infrared spectroscopy (FTIR), and electronic nose (E-nose), either individually or in combination, are efficient in distinguishing adulterated Indian ghee. These findings could serve as a reference for the detection of adulteration in Tibetan butter in the future.

Although the giant panda (Ailuropoda melanoleuca) relies almost exclusively on bamboo, its carnivore-like gastrointestinal tract has limited capacity for fiber digestion. The gut microbiota contributes to bamboo-derived nutrient utilization, although the extent of this contribution remains limited. Captivity-associated dietary and environmental changes frequently disrupt this microbial ecosystem, resulting in impaired digestive function and reduced physiological resilience. Conventional interventions, including antibiotics and single-strain probiotics, are generally insufficient to restore the complexity and stability of the gut microbiota. Fecal microbiota transplantation (FMT), which reconstructs the gut microbial ecosystem by transferring an intact microbial community, has demonstrated therapeutic potential in humans and various animal models. However, its feasibility in giant pandas remains unclear because their short intestinal tract, absence of fermentation chambers, rapid gastrointestinal transit, and host-mediated ecological filtering substantially limit donor microbiota engraftment. This review evaluates the biological rationale and technical feasibility of oral FMT in giant pandas by integrating evidence from gastrointestinal physiology, microbial ecology, and conservation medicine. This review identifies the principal barriers to microbial engraftment. It synthesizes a giant panda-specific framework from the available literature, encompassing function-oriented donor selection, optimized microbial delivery strategies, and multidimensional efficacy assessment. Collectively, this synthesis provides a theoretical foundation for future FMT research in giant pandas and offers a conceptual reference for microbiota-based interventions in the conservation of endangered wildlife.